Shareholders Equity ratio Analysis of Immuneering Corp - Deep Dive


Shareholders Equity of IMRX
Dec-23
88.29
Excellent Shareholders Equity
Dec-22
89.77
Excellent Shareholders Equity
Growth
-1.65
%
Shareholders Equity Analysis of Immuneering Corp
Shareholder to Equity Ratio of Immuneering Corp with value of 88.29 indicates that shareholders own a High proportion of the assets of the company.
Shareholders Equity Ratio of IMRX has fallen by -1.65 % Compared to previous Financial Year.
Shareholders Equity Ratio with value of 93.57 was highest in Year Dec-21 in last Five Years.
Shareholders Equity Ratio with value of -58.51 was lowest in Year Dec-20 in last Five Years.
Latest Shareholders Equity Ratio with value of 88.29 is Greater than Average Shareholders Equity of 33.37 in last five years.
Other Shareholders Equity Related Info of IMRX that may interest you.
Immuneering Corp Overview
CodePricePrevious PricePrice ChangeSector
IMRX1.471.54 4.55 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation.    more ..
Shareholders Equity Formula

Shareholders Equity Related Ratios
DebtToEquityRatioReturnOnEquity

Tsr Stability Index
Mild Stability
FY - Historical Shareholders Equity of Immuneering Corp
PeriodDec-23Dec-22Dec-21Dec-20Dec-19
Shareholders Equity88.2989.7793.57-58.51-46.29
Change-1.65 %-4.06 %259.91 %-26.39 %
FY Chart of Shareholders Equity of Immuneering Corp


Note : All Data Generated at the End of Trading Hours (EOD Data)